TGF‐β1 expression is elevated in astrocytes in both murine and human ALS models, and pharmacological inhibition of TGF‐β signaling post disease onset has been shown to prolong survival in SOD1 mice [114]. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.